{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:47:29Z","timestamp":1790480849318,"version":"4.1.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,8,15]]},"DOI":"10.1097\/01.tp.0000073809.65502.8f","type":"journal-article","created":{"date-parts":[[2003,12,2]],"date-time":"2003-12-02T06:48:39Z","timestamp":1070347719000},"page":"459-463","source":"Crossref","is-referenced-by-count":72,"title":["Anaphylactic shock caused by immunoglobulin E sensitization after retreatment with the chimeric anti\u2013interleukin-2 receptor monoclonal antibody basiliximab"],"prefix":"10.1097","volume":"76","author":[{"given":"V\u00e9ronique","family":"Baudouin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Crusiaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliane","family":"Schandene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Loirat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Abramowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210129","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(97)09278-7","article-title":"Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients: CHIB 201 International Study Group","volume":"350","author":"Nashan","year":"1997","journal-title":"Lancet"},{"key":"R2-3-20210129","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199801153380304","article-title":"Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation: Daclizumab Triple Therapy Study Group","volume":"338","author":"Vincenti","year":"1998","journal-title":"N Engl J Med"},{"key":"R3-3-20210129","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00007890-199901270-00016","article-title":"Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody: United States Simulect Renal Study Group","volume":"67","author":"Kahan","year":"1999","journal-title":"Transplantation"},{"key":"R4-3-20210129","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00007890-199901150-00019","article-title":"Reduction of acute renal allograft rejection by daclizumab: Daclizumab Double Therapy Study Group","volume":"67","author":"Nashan","year":"1999","journal-title":"Transplantation"},{"key":"R5-3-20210129","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/00007890-200110150-00014","article-title":"A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients","volume":"72","author":"Ponticelli","year":"2001","journal-title":"Transplantation"},{"key":"R6-3-20210129","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/00007890-200112270-00008","article-title":"Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection","volume":"72","author":"Sollinger","year":"2001","journal-title":"Transplantation"},{"key":"R7-3-20210129","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/00007890-199510150-00023","article-title":"Prolonged action of a chimeric interleukin-2 receptor (CD25) monoclonal antibody used in cadaveric renal transplantation","volume":"60","author":"Amlot","year":"1995","journal-title":"Transplantation"},{"key":"R8-3-20210129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00007890-199701150-00007","article-title":"A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation","volume":"63","author":"Vincenti","year":"1997","journal-title":"Transplantation"},{"key":"R9-3-20210129","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1097\/00007890-199712270-00012","article-title":"Disposition of basiliximab, an interleukin-2 receptor monoclonal antibody, in recipients of mismatched cadaver renal allografts","volume":"64","author":"Kovarik","year":"1997","journal-title":"Transplantation"},{"key":"R10-3-20210129","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00007890-199602270-00011","article-title":"The IgE humoral response in OKT3-treated patients: Incidence and fine specificity","volume":"61","author":"Abramowicz","year":"1996","journal-title":"Transplantation"},{"key":"R11-3-20210129","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1056\/NEJM199209033271018","article-title":"Anaphylactic shock after retreatment with OKT3 monoclonal antibody","volume":"327","author":"Abramowicz","year":"1992","journal-title":"N Engl J Med"},{"key":"R12-3-20210129","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1073\/pnas.78.7.4031","article-title":"Multiple amino acid substitutions between murine gamma 2a heavy chain Fc regions of Ig1a and Ig1b allotypic forms","volume":"78","author":"Dognin","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"R13-3-20210129","first-page":"1967","article-title":"Localization of murine Igh-1a allotypic determinants by using a panel of mouse myeloma variant immunoglobulins","volume":"130","author":"Oi","year":"1983","journal-title":"J Immunol"},{"key":"R14-3-20210129","first-page":"913","article-title":"Prolonged immunosuppressive effect and minimal immunogenicity from chimeric (CD25) monoclonal antibody SDZ CHI 621 in renal transplantation","volume":"28","author":"Kovarik","year":"1996","journal-title":"Transplant Proc"},{"key":"R15-3-20210129","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1097\/00007890-200212270-00009","article-title":"Safe administration of a humanized murine antibody after anaphylaxis to a chimeric murine antibody","volume":"74","author":"Leonard","year":"2002","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.TP.0000073809.65502.8F","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:03:27Z","timestamp":1785783807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200308150-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8,15]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000073809.65502.8f","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2003,8,15]]}}}